1. Home
  2. NSPR vs GMHS Comparison

NSPR vs GMHS Comparison

Compare NSPR & GMHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • GMHS
  • Stock Information
  • Founded
  • NSPR 2005
  • GMHS N/A
  • Country
  • NSPR United States
  • GMHS China
  • Employees
  • NSPR N/A
  • GMHS N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • GMHS
  • Sector
  • NSPR Health Care
  • GMHS
  • Exchange
  • NSPR Nasdaq
  • GMHS NYSE
  • Market Cap
  • NSPR 75.1M
  • GMHS 85.7M
  • IPO Year
  • NSPR N/A
  • GMHS N/A
  • Fundamental
  • Price
  • NSPR $2.44
  • GMHS $1.74
  • Analyst Decision
  • NSPR Strong Buy
  • GMHS
  • Analyst Count
  • NSPR 2
  • GMHS 0
  • Target Price
  • NSPR $4.50
  • GMHS N/A
  • AVG Volume (30 Days)
  • NSPR 386.2K
  • GMHS 9.9K
  • Earning Date
  • NSPR 08-05-2025
  • GMHS 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • GMHS N/A
  • EPS Growth
  • NSPR N/A
  • GMHS N/A
  • EPS
  • NSPR N/A
  • GMHS 0.03
  • Revenue
  • NSPR $7,027,000.00
  • GMHS $119,023,021.00
  • Revenue This Year
  • NSPR $4.85
  • GMHS N/A
  • Revenue Next Year
  • NSPR $113.47
  • GMHS N/A
  • P/E Ratio
  • NSPR N/A
  • GMHS $63.31
  • Revenue Growth
  • NSPR 8.49
  • GMHS N/A
  • 52 Week Low
  • NSPR $1.99
  • GMHS $0.96
  • 52 Week High
  • NSPR $3.80
  • GMHS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 54.16
  • GMHS N/A
  • Support Level
  • NSPR $2.12
  • GMHS N/A
  • Resistance Level
  • NSPR $2.46
  • GMHS N/A
  • Average True Range (ATR)
  • NSPR 0.16
  • GMHS 0.00
  • MACD
  • NSPR 0.01
  • GMHS 0.00
  • Stochastic Oscillator
  • NSPR 73.33
  • GMHS 0.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About GMHS GAMEHAUS HOLDINGS INC

Gamehaus Holdings Inc is a technology-driven mobile game publishing company for small- and medium-sized game developers. It built a diverse game portfolio across multiple genres, including social casino, match, simulation, RPG, puzzle, and bingo, others, and distributes mobile games created by developer partners across a wide range of gaming markets, including in countries such as the U.S., the U.K., Australia, Germany, France, Canada, Brazil, Japan, and India, among others. The company offers a comprehensive package of services covering all aspects of the game life cycle, including (i) game development, (ii) screening and pre-publication testing, (iii) user acquisition, and (iv) monetization.

Share on Social Networks: